Thiazide diuretics in hypertension

Clinical and Experimental Hypertension

Volumn 21, Issue 5-6, 1999, Pages 805-814

  Ramsay, Lawrence E ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Coronary disease; Dose response; Hypertension; Side effects; Stroke; Thiazides

Indexed keywords

ANTIHYPERTENSIVE AGENT; LITHIUM; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE ACTIVITY; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; GOUT; HEART FAILURE; HUMAN; HYPERTENSION; HYPERURICEMIA; HYPOKALEMIA; IMPOTENCE; KIDNEY FAILURE; STROKE;

EID: 0032769273     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909061010     Document Type: Conference Paper

References (34)

1. Ramsay, L.E., Yeo, W.W., Chadwick, I.G., Jackson, P.R. Diuretics. In Textbook of Hypertension., ed J. D. Swales. Blackwell Scientific Publications. Oxford 1994. pp 1046-1058.
2. Treatment of Mild Hypertension Research Group. The Treatment of Mild Hypertension Study: a randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med 1991;151:1413-1423.
3. Neaton, J.D., Grimm, R.H., Prineas, R.J., Stamler, J., Grandits, G.A., Elmer, P.J., et al, for the Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study. Final results. JAMA 1993;270:713-724.
4. Materson, B.J., Reda, D. J., Cushman, W.C., Massie, B.M., Freis, E.D., Kochar, M.S., et al for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-921.
5. Philipp, T., Anlauf, M., Distler, A., Holzgreve, H., Michaelis, J., Wellek, S., on behalf of the HANE Trial Research Group. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. BMJ 1997;315:154-159.
6. Materson, B.J., Reda, D.J., Cushman, W.C., Henderson, W.G., for the Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents. Results of combination anti-hypertensive therapy after failure of each of the components. J Hum Hypertens 1995;9:791-796.
7. Cusi, D., Barlassina, C., Azzani, T., Casari, G., Citterio, L., Devoto, M., et al. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997;349:1353-1357.
8. Parijs, J., Joosens, J.V., Van der Linden, L., Verstrecken, G., Amery, A.K. Moderate sodium restriction and diuretics in the treatment of hypertension. Am Heart J 1973;85:22-34.
9. Ram, C.V.S., Garrett, B.M., Kaplan, N.M. Moderate sodium restriction and various diuretics in the treatment of hypertension: effects of potassium wastage and blood pressure control. Arch Intern Med 1981;141:1015-1019.
10. Carlsen, J.E., Kober, L., Torp-Pedersen, C., Johansen, P. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ 1990;300:975-978.
11. Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 1981;2:539-543.
12. Helgeland, A., Strommen, R., Hagulund C., Tretli, S. Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. Lancet 1986;1:872-875.
13. Waller, P.C., Ramsay, L.E. Predicting acute gout in diuretic-treated hypertensive patients. J Hum Hypertens 1989;3:457-461.
14. Collins, R., Yusuf, S., Peto, R. Overview of randomised trials of diuretics in pregnancy. BMJ 1985;290:17-23.
15. Curb, J.D., Pressel, S.L., Cutler, J.A., et al, for the Systolic Hypertension in the Elderly Program Co-operative Research Group. Advantage of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996;276:1886-1892.
16. McInnes, G.T., Yeo, W.W., Ramsay, L.E., Moser, M. Cardiotoxicity and diuretics; much speculation - little substance. J Hypertens 1992;10:317-335.
17. Grimm, R.H., Flack, J.M., Grandits, G.A., Elmer, P.J., Neaton, J.D., Cutler, J. A., et al, for the Treatment of Mild Hypertension Study (TOMHS) Research Group. Long-term effects on plasma lipids of diet and drugs to treat hypertension. JAMA 1996;275:1549-1556.
18. Collins, R., Peto, R., MacMahon, S., Hebert, P., Fiebach, N.H., Eberlein, K.A., et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-838.
19. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
20. Thijs, L., Fagard, R., Lijnen, P., Staessen, J., Van Hoof, R., Amery, A. A meta-analysis of outcome trials in elderly hypertensives. J Hypertens 1992;10:1103-1109.
21. Medical Research Council Working Party: MRC trial of treatment of mild hypertension: principle results. BMJ 1985;291:97-104.
22. The IPPPSH Collaborative Group:Cardiovascular risk and risk factors in randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). J Hypertens 1985;3:379-392.
23. Wilhelmsen, L., Berglund, G., Elmfeldt, D., Fitzsimons, T., Holzgreve, H., Hosie, J., et al: Beta-blockers versus diuretics in hypertensive men:main results from the HAPPHY trial. J Hypertens 1987;5:561-572.
24. Peart, S., Brennan, P.J., Broughton, P., et al, on behalf of the MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992;304:405-412.
25. Staessen, J.A., Fagard, R., Thijs, L., et al, for the Systolic Hypertension-Europe (Syst-Eur) Trial Investigators. Morbidity and mortality in the placebo-controlled European trial on isolated systolic hypertension in the elderly. Lancet 1997;360:757-764.
26. Andersson, O.K., Almgren,T., Persson, B., Samuelsson, O., Hedner, T., Wilhelmsen, L. Survival in treated hypertension: follow up study after two decades. BMJ 1998;317:167-171.
27. Samuelsson, O., Pennert, K., Andersson, O., Berglund, G., Hedner, T., Persson, B., et al. Diabetes mellitus and raised serum triglyceride concentration in treated hypertension - are they of prognostic importance? Observational study. BMJ 1996;313:660-663.
28. Psaty, B.M., Smith, N.L., Siscovick, D.S., Koepsell, T.D., Weiss, N.S., Heckbert, S.R., et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997;277:739-745.
29. Siscovick, D.S., Raghunathan, T.E., Psaty, B.M., Koepsell, T.D., Wicklund, K.G., Lin, X., et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994;330:1852-1857.
30. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC-V). Arch Intern Med 1993;153:154-183.
31. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-2446.
32. Sever, P., Beevers, G., Bulpitt, C., Lever, A., Ramsay, L., Reid, J., et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993;306:983-987.
33. WHO-ISH Guidelines Subcommittee: Guidelines for the management of mild hypertension: memorandum from a World Health Organisation/International Society of Hypertension meeting. J Hypertens 1993;11:905-918.
34. Ramsay, L.E., Wallis, E.J., Yeo, W.W., Jackson, P.R. The rationale for differing national recommendations for the treatment of hypertension. Am J Hypertens 1998;11:79S-88S